Your browser doesn't support javascript.
loading
Quantum Defect Sensitization via Phase-Changing Supercharged Antibody Fragments.
Kim, Mijin; McCann, James J; Fortner, Jacob; Randall, Ewelina; Chen, Chen; Chen, Yu; Yaari, Zvi; Wang, YuHuang; Koder, Ronald L; Heller, Daniel A.
Afiliación
  • Kim M; Molecular Pharmacology Program, Sloan Kettering Institute, New York, New York 10065, United States.
  • McCann JJ; School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
  • Fortner J; Department of Physics, City College of New York, New York, New York 10031, United States.
  • Randall E; Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States.
  • Chen C; Chemical Physics Program, University of Maryland, College Park, Maryland 20742, United States.
  • Chen Y; Molecular Pharmacology Program, Sloan Kettering Institute, New York, New York 10065, United States.
  • Yaari Z; Molecular Pharmacology Program, Sloan Kettering Institute, New York, New York 10065, United States.
  • Wang Y; Graduate School of Medical Sciences, Weill Cornell Medicine, New York, New York 10065, United States.
  • Koder RL; Department of Physics, City College of New York, New York, New York 10031, United States.
  • Heller DA; Molecular Pharmacology Program, Sloan Kettering Institute, New York, New York 10065, United States.
J Am Chem Soc ; 146(18): 12454-12462, 2024 May 08.
Article en En | MEDLINE | ID: mdl-38687180
ABSTRACT
Quantum defects in single-walled carbon nanotubes promote exciton localization, which enables potential applications in biodevices and quantum light sources. However, the effects of local electric fields on the emissive energy states of quantum defects and how they can be controlled are unexplored. Here, we investigate quantum defect sensitization by engineering an intrinsically disordered protein to undergo a phase change at a quantum defect site. We designed a supercharged single-chain antibody fragment (scFv) to enable a full ligand-induced folding transition from an intrinsically disordered state to a compact folded state in the presence of a cytokine. The supercharged scFv was conjugated to a quantum defect to induce a substantial local electric change upon ligand binding. Employing the detection of a proinflammatory biomarker, interleukin-6, as a representative model system, supercharged scFv-coupled quantum defects exhibited robust fluorescence wavelength shifts concomitant with the protein folding transition. Quantum chemical simulations suggest that the quantum defects amplify the optical response to the localization of charges produced upon the antigen-induced folding of the proteins, which is difficult to achieve in unmodified nanotubes. These findings portend new approaches to modulate quantum defect emission for biomarker sensing and protein biophysics and to engineer proteins to modulate binding signal transduction.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Teoría Cuántica Límite: Humans Idioma: En Revista: J Am Chem Soc Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Teoría Cuántica Límite: Humans Idioma: En Revista: J Am Chem Soc Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos